Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The purpose of this study is to evaluate if Dapagliflozin has direct effect on alpha cell glucagon release.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Males and females aged 18 - 75.
Female subjects must meet all of the following criteria:
i. Diaphragm or partner use of condom in combination with combined (estrogen and progestogen containing) hormonal contraception associated with inhibition of ovulation:
BMI 20 - 35.
Clinical T2D diagnosis at least 6 months prior to enrolment.
Metformin treatment, with stable dose for at least 1 month.
HbA1c 55 - 86 mmol/mol (7,2-10 % DCCT).
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
15 participants in 6 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal